Abivax receives $920 million in cash to prepare for US launch: CEO
AbivaxThe latest round of funding allows the biotech to move toward launching its intestinal disease drug in the United States…
Abivax SA
Abivax shares soar after new data on drugs for intestinal diseases
Shares of a French biotechnology company Abivax surged on Tuesday after it released new data on its lead drug for…
Abivax Shares Plunge Amid Cancer Cases in Bowel Disease Drug Trial
Actions of Abivax It closed down 43.6% on Tuesday after reporting new data on its top asset, an ulcerative colitis…
Abivax Stock Rises to Become Top Biotech Acquisition Target
Europe's best-performing blue-chip stocks in 2025 are expected to be bought by a larger peer, in a deal analysts say…